Rybelsus 14 mg Tablet contains Semaglutide 14 mg, an innovative oral GLP-1 receptor agonist widely prescribed for the management of Type 2 Diabetes Mellitus. As one of the first oral semaglutide formulations available globally, Rybelsus offers a convenient alternative to injectable therapies while supporting effective blood glucose management.
Truvalis Healthcare specializes in sourcing and supplying genuine Rybelsus 14 mg tablets for international patients, pharmacies, distributors, importers, hospitals, and healthcare organizations.
We support worldwide pharmaceutical sourcing requirements and can assist with:


Price:
Price 230 INR / Vial
Minimum Order Quantity : 10 Vials
Dosage : As directed by physician, typically once daily at the same time each day
Function : Other, Longacting blood glucose lowering agent (basal insulin)
Dosage Form : Injectable solution
Ingredients : Insulin Glargine (rDNA origin)
Price 5000 INR / Vial
Minimum Order Quantity : 10 Vials
Dosage : 0.75 mg once weekly or as directed by the physician
Function : Other, Antidiabetic, Glucagonlike peptide1 (GLP1) receptor agonist
Dosage Form : Solution for injection
Ingredients : Semaglutide
Price 2950.0 INR / Box
Minimum Order Quantity : 1 Box
Dosage : As directed by physician
Function : Other
Dosage Form : Oral
Ingredients : Semaglutide 3mg
Price 3098.0 INR / Unit
Minimum Order Quantity : 5 Units
Dosage : 7mg once daily or as prescribed by physician
Function : Other
Dosage Form : Oral Tablets
Ingredients : Semaglutide